These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22936797)

  • 21. Interaction of thrombospondin-1 and heparan sulfate from endothelial cells. Structural requirements of heparan sulfate.
    Feitsma K; Hausser H; Robenek H; Kresse H; Vischer P
    J Biol Chem; 2000 Mar; 275(13):9396-402. PubMed ID: 10734084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche.
    Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
    Blood; 1998 Dec; 92(12):4641-51. PubMed ID: 9845530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
    Jaikaran ET; Clark A
    Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor.
    Mirecka EA; Feuerstein S; Gremer L; Schröder GF; Stoldt M; Willbold D; Hoyer W
    Sci Rep; 2016 Sep; 6():33474. PubMed ID: 27641459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet amyloid polypeptide triggers limited complement activation and binds complement inhibitor C4b-binding protein, which enhances fibril formation.
    Sjölander J; Westermark GT; Renström E; Blom AM
    J Biol Chem; 2012 Mar; 287(14):10824-33. PubMed ID: 22334700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide.
    Smith PE; Brender JR; Ramamoorthy A
    J Am Chem Soc; 2009 Apr; 131(12):4470-8. PubMed ID: 19278224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Islet amyloid polypeptide fibril catalyzes amyloid-β aggregation by promoting fibril nucleation rather than direct axial growth.
    Song Z; Tang H; Gatch A; Sun Y; Ding F
    Int J Biol Macromol; 2024 Nov; 279(Pt 1):135137. PubMed ID: 39208885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity.
    De Carufel CA; Nguyen PT; Sahnouni S; Bourgault S
    Biopolymers; 2013 Nov; 100(6):645-55. PubMed ID: 23526456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.
    Aston-Mourney K; Zraika S; Udayasankar J; Subramanian SL; Green PS; Kahn SE; Hull RL
    J Biol Chem; 2013 Feb; 288(5):3553-9. PubMed ID: 23229548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet amyloid polypeptide and type 2 diabetes.
    Marzban L; Park K; Verchere CB
    Exp Gerontol; 2003 Apr; 38(4):347-51. PubMed ID: 12670620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.
    Meng F; Abedini A; Plesner A; Verchere CB; Raleigh DP
    Biochemistry; 2010 Sep; 49(37):8127-33. PubMed ID: 20707388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of preamyloid intermediates: the role of his-tyr interactions in islet amyloid formation.
    Tu LH; Serrano AL; Zanni MT; Raleigh DP
    Biophys J; 2014 Apr; 106(7):1520-7. PubMed ID: 24703313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Fluorogenic Molecule for Probing Islet Amyloid Using Flavonoid as a Scaffold Design.
    Chen WL; Ma ST; Chen YW; Chao YC; Chan AC; Tu LH; Liu WM
    Biochemistry; 2020 Apr; 59(15):1482-1492. PubMed ID: 32266809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet amyloid polypeptide in pancreatic islets from type 2 diabetic subjects.
    Tomita T
    Islets; 2012; 4(3):223-32. PubMed ID: 22847497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disaggregation of Islet Amyloid Polypeptide Fibrils as a Potential Anti-Fibrillation Mechanism of Tetrapeptide TNGQ.
    Abioye RO; Okagu OD; Udenigwe CC
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hsp72 (HSPA1A) Prevents Human Islet Amyloid Polypeptide Aggregation and Toxicity: A New Approach for Type 2 Diabetes Treatment.
    Rosas PC; Nagaraja GM; Kaur P; Panossian A; Wickman G; Garcia LR; Al-Khamis FA; Asea AA
    PLoS One; 2016; 11(3):e0149409. PubMed ID: 26960140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective.
    Brender JR; Salamekh S; Ramamoorthy A
    Acc Chem Res; 2012 Mar; 45(3):454-62. PubMed ID: 21942864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of lysine residue of islet amyloid polypeptide in fibril formation, membrane binding, and inhibitor binding.
    Wu MH; Chan AC; Tu LH
    Biochimie; 2020 Oct; 177():153-163. PubMed ID: 32860895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology.
    Cao P; Abedini A; Raleigh DP
    Curr Opin Struct Biol; 2013 Feb; 23(1):82-9. PubMed ID: 23266002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.